Pean P, Madec Y, Nerrienet E, Borand L, Laureillard D, et al.
2023-10-13 • Pathogens
2023-10-13 • Pathogens
IRIS is a common complication in HIV-infected patients treated for tuberculosis (TB) and cART. Our aim was to evaluate NK cell reconstitution in HIV-infected patients with TB-IRIS compar...
Laureillard D, Marcy O, Madec Y, Chea S, Chan S, et al.
2013-10-23 • AIDS
2013-10-23 • AIDS
To analyze cases of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the CAMbodian Early versus Late Introduction of Antiretrovirals (CAMELIA)...
Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al.
2011-10-20 • New England Journal of Medicine
2011-10-20 • New England Journal of Medicine
Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation...
Fernandez MAL, Schomaker M, Mason PR, Fesselet JF, Baudot Y, et al.
2012-06-18
2012-06-18
BACKGROUND In highly populated African urban areas where access to clean water is a challenge, water source contamination is one of the most cited risk factors in a cholera epidemic....
Ousley J, Soe KT, Kyaw NTT, Anicete R, Mon PE, et al.
2018-03-21 • Public Health Action
2018-03-21 • Public Health Action
Setting: A southern Myanmar district providing isoniazid preventive therapy (IPT) in one of the last countries to formally recommend it as part of human immunodeficiency virus (HIV) care...
Fernandez MAL, Schomaker M, Mason PR, Fesselet JF, Baudot Y, et al.
2012-06-18 • BMC Public Health
2012-06-18 • BMC Public Health
BACKGROUND In highly populated African urban areas where access to clean water is a challenge, water source contamination is one of the most cited risk factors in a cholera epidemic....
Ousley J, Nesbitt RC, Kyaw NTT, Bermudez E, Soe KT, et al.
2018-12-14 • BMC Infectious Diseases
2018-12-14 • BMC Infectious Diseases
BACKGROUND In Southeast Asia, though fishermen are known to be a key population at high risk of HIV, little is known about their co-infection rates with Hepatitis C virus (HCV), or h...
Pean P, Nouhin J, Ratana M, Madec Y, Borand L, et al.
2019-08-27 • Frontiers in Immunology
2019-08-27 • Frontiers in Immunology
Background: Human Immunodeficiency Virus 1 (HIV-1) and Mycobacterium Tuberculosis (Mtb) co-infected patients are commonly at risk of immune reconstitution inflammatory syndrome (IRIS) wh...
Kyaw NTT, Harries AD, Chinnakali P, Antierens A, Soe KT, et al.
2015-08-24 • PLOS One
2015-08-24 • PLOS One
BACKGROUND Since 2004, Médecins Sans Frontières-Switzerland has provided treatment and care for people living with HIV in Dawei, Myanmar. Renal function is routinely monitored in pat...
Madec Y, Laureillard D, Pinoges LLP, Fernandez MAL, Prak N, et al.
2007-01-30 • AIDS
2007-01-30 • AIDS
BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients. METHODS: Factors associated...
Ferradini LLF, Laureillard D, Prak N, Ngeth C, Fernandez MAL, et al.
2007-11-12 • AIDS
2007-11-12 • AIDS
OBJECTIVES: African and Asian cohort studies have demonstrated the feasibility and efficacy of HAART in resource-poor settings. The long-term virological outcome and clinico-immunologica...
Bermudez-Aza EH, Shetty S, Ousley J, Kyaw NTT, Soe TT, et al.
2018-02-08 • PLOS One
2018-02-08 • PLOS One
OBJECTIVE To study the long-term clinical, immunological and virological outcomes among people living with HIV on antiretroviral therapy (ART) in Myanmar.
